Indian scientists have great success related to Breast Cancer, now the illness is no longer incurable!

Breast Cancer : Indian scientists have achieved great success about breast cancer. Researchers from the National Institute of Biomedical Genomics (NIBMG), Kalyani and Tata Memorial Center (TMC), Mumbai have identified mutations in three genes and other unusual genetic systems, which again in women who have treated breast cancer in this disease Increases the risk of being from

Researchers have said that this study has found that genetic testing may be possible, which will estimate the possibility of the disease re -having the disease in breast cancer patients, which can help in treating.

Also read: So HIV infection will increase rapidly in the world, who knows and why warning

How effective this search

Scientists found that women with 3 gene mutations are at 2.4 times higher in the 5 years of treating hormone receptor positive breast cancer in 5 years, which is 50 to 60 percent of such tumors worldwide including India including India. . Most patients with hormone-sipter breast cancer, anti-estrogen molecules and other cancer drugs allegedly react to endocrine therapy, but 20 to 40 percent of all women suffering from breast cancer would rebuild it again. Is.

How to get breast cancer again

According to this study published in Communications Biology, a significant part of hormone-attending-positive breast cancer cancer patients produce resistance to endocrine therapy. In the treatment of breast cancer, it was found that due to such resistance, there is a risk of re -having 10 percent again and up to 30 percent metastasis, which is the condition of spreading in other organs such as breast cancer tumors, bones, liver or lungs.

Also read: What happens postpartum depression, know how to get rid of how to get after pregnancy

What do scientists say

NIBMG, Associate Professor and Cancer Genomics Expert and Study Nidhan Biswas said that there is no complete information about the genetic system behind this resistance. This study was designed to examine genetic factors that helped in this resistance. Biswas, along with Professor Sudeep Gupta and others of Medical Oncology at TMC, analyzed genome with a sample of tumor tissue of 20 women with endocrine-reactive tumors and 20 women with endocrine-resistant tumors.

He found mutations in three special genes named Pik3CA, ESR1 and TP53 in 40 percent of treatment-resistant tumors, while in therapy-reactive tumors, only 5 percent of the mutations were found in the therapy-reactive tumors, which suggests that the risk of regaining breast cancer from mutation itself Grows.

Disclaimer: Here information provided here is based only on beliefs and information. It is important to tell here that ABPLive.com No recognition, does not confirm the information. Before implementing any information or recognition, consult the concerned expert.

Also read: ‘I don’t have to live anymore …’ Deepika Padukone told the students the story of her depression